Skip to main content
Signal8

SILVERARC CAPITAL MANAGEMENT, LLC

SILVERARC CAPITAL MANAGEMENT, LLC is an Investment Adviser institutional filer with the SEC under CIK 1816307, reporting 65 portfolio positions, with 19 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-13

Top 10 portfolio positions

The largest reported holdings in SILVERARC CAPITAL MANAGEMENT, LLC's most recent 13F filing, ranked by reported market value.

  1. ASCENDIS PHARMA A/S (ASND)
  2. CELCUITY INC (CELC)
  3. COGENT BIOSCIENCES INC (COGT)
  4. UROGEN PHARMA LTD (URGN)
  5. IMMUNOME INC (IMNM)
  6. DIANTHUS THERAPEUTICS INC (DNTH)
  7. RHYTHM PHARMACEUTICALS INC (RYTM)
  8. ORUKA THERAPEUTICS INC (ORKA)
  9. MONTE ROSA THERAPEUTICS INC (GLUE)
  10. SYNDAX PHARMACEUTICALS INC (SNDX)
/